A phase separation delivery type alcoholism-preventing and liver-protecting composition based on regulation of the liver-gut axis and a preparation method thereof
This product utilizes a phased delivery-type hangover relief and liver protection composition based on hepato-gut axis regulation. It employs food-derived components that promote metabolism, components that regulate the hepato-gut axis and promote acetaldehyde metabolism, and components that form a film in the stomach and provide sustained release in the intestine. This approach addresses several shortcomings of existing hangover relief and liver protection products, achieving systematic intervention and highly effective hangover relief and liver protection.
Patent Information
- Application Number
- CN202611345817.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-01
- Publication Date
- 2026-11-13
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] This invention relates to hangover remedies, and in particular to a phased delivery hangover remedy and liver-protecting composition based on gut-liver axis regulation and its preparation method. Background Technology
[0002] Alcoholic liver injury is a major public health problem worldwide. Statistics show that the number of drinkers in my country has exceeded 600 million, and the prevalence of alcoholic liver disease (ALD) is increasing year by year, becoming the second leading cause of liver disease after viral hepatitis. The metabolism of alcohol in the body mainly occurs in the liver, where it is converted to acetaldehyde by alcohol dehydrogenase (ADH), and then to acetic acid by aldehyde dehydrogenase (ALDH). Acetaldehyde is a highly toxic intermediate metabolite that can cause oxidative stress, inflammatory responses, and hepatocyte apoptosis, and is a core factor leading to hangover symptoms and liver damage.
[0003] Currently available hangover remedies and liver protection products suffer from the following technical deficiencies: (1) Single target and lack of systemic intervention: Existing products are mostly developed around a "licorice-kudzu root" binary formula, which works by promoting the activity of alcohol-metabolizing enzymes, targeting only a single site in the liver. However, recent research shows that the gut-liver axis, rather than the liver alone, synergistically drives systemic acetaldehyde clearance. Long-term alcohol consumption can damage the intestinal mucosal barrier, induce intestinal microbiota imbalance, and cause abnormal bile acid metabolism, mediating hepatic steatosis and a pro-inflammatory environment through microbiota translocation and endotoxemia. Existing products generally neglect upstream pathological processes such as intestinal flora imbalance and intestinal barrier damage, making it difficult to achieve synergistic protection of the "gut-liver"; (II) Low bioavailability of active ingredients and delayed onset of action: Most hangover relief products use ordinary oral preparations, which have two major bottlenecks: First, the core ingredients such as puerarin and dihydromyricetin have poor water solubility and are significantly affected by the first-pass effect of the liver, with actual bioavailability of less than 10%; Second, alcohol is absorbed very quickly through the gastrointestinal tract, and the blood drug concentration reaches its peak 30-60 minutes after drinking, while traditional preparations are often absorbed late, missing the best intervention window; (III) Insufficient synergy of formulations and unclear dose-effect relationship: Plant extracts lack uniform specifications due to different raw material origins and extraction methods, and excessive use may lead to abnormal liver enzymes. Ingredients such as curcumin and silymarin have shortcomings such as low bioavailability and easy irritation to the gastrointestinal tract. In addition, the synergistic mechanism between vitamin B complex, amino acids and other nutritional supplements and plant extracts is not well studied, and the formulas are mostly simple superpositions without scientific compatibility basis; (iv) backward delivery technology and lack of precise controlled release: most existing hangover relief products are ordinary tablets, capsules or oral liquids, which cannot achieve precise delivery in time and space. At the beginning of drinking, the ethanol concentration in the stomach is the highest. If a physical barrier can be formed in the stomach to delay absorption and at the same time some hangover relief components are released locally, the peak blood alcohol level can be significantly reduced. However, existing products cannot achieve phased delivery of "gastric retention-intestinal slow release", which is difficult to match the absorption and metabolism rhythm of alcohol in the body; (v) probiotic products have stability problems: some new generation hangover relief products introduce active probiotics, but live bacteria preparations have problems such as gastric acid inactivation, low intestinal colonization rate and harsh storage conditions, which greatly reduces the actual efficacy. Postbiotics, as inactivated bacteria and their metabolites of probiotics, have advantages such as high stability, good safety and easy dosage control, but their systematic application in the field of hangover relief and liver protection has not been reported.
[0004] Therefore, developing a novel alcohol-relieving and liver-protecting composition based on the theory of hepatobiliary axis regulation, employing phased delivery technology, and featuring multi-target synergistic effects is of significant clinical importance and market value for improving alcoholic liver damage and enhancing alcohol detoxification effects. Summary of the Invention
[0005] In view of the above situation and to overcome the shortcomings of the existing technology, the purpose of this invention is to provide a phased delivery type hangover relief and liver protection composition based on the liver-gut axis regulation and its preparation method. It can effectively solve the problems of existing hangover relief and liver protection products, such as single target of action, lack of systematic intervention, low bioavailability of active ingredients, delayed onset of action, insufficient synergy of formulation, unclear dose-effect relationship, backward delivery technology, lack of precise controlled release, and insufficient stability of probiotic products.
[0006] The technical solution provided by this invention is: a phased delivery type of hangover relief and liver protection composition based on hepato-gut axis regulation, comprising a food-derived metabolizing component, a hepato-gut axis regulating and acetaldehyde metabolism promoting component, and a gastric film-forming and intestinal sustained-release carrier component. The food-derived metabolizing component is 30-75 parts of a food-derived compound extract. The hepato-gut axis regulating and acetaldehyde metabolism promoting component consists of 5-25 parts of probiotic post-biotic powder, 5-20 parts of corn oligopeptides, 1-8 parts of taurine, 0.5-5 parts of L-cysteine, 0.5-5 parts of L-alanine, 0.05-0.5 parts of vitamin B1, 0.05-0.5 parts of vitamin B2, and vitamin B6. The gastric film-forming and intestinal sustained-release carrier components are composed of 0.05-0.5 parts of nicotinamide, 0.05-1 parts of L-theanine, and 0.5-5 parts of sodium alginate, 3-15 parts of low-methoxyl pectin, 2-12 parts of sodium alginate, 5-25 parts of resistant dextrin, 0.5-5 parts of chitosan, 0.5-5 parts of calcium carbonate, 0.5-5 parts of sodium citrate, 5-50 parts of maltodextrin, 5-30 parts of erythritol, 1-2 parts of citric acid, 1-2 parts of magnesium stearate, and 0.2-1.5 parts of peppermint flavor.
[0007] S1. Preparation of extracts derived from both food and medicine: Take the following ingredients in a weight ratio of 10:8:4:3:2:1: crush the following herbs: Hovenia dulcis, Pueraria lobata, Pueraria lobata flower, Hippophae rhamnoides, Citrus reticulata peel, and Glycyrrhiza uralensis, and pass them through a 20-mesh sieve. Add 10 times the weight volume of purified water to the crushed Hovenia dulcis, Pueraria lobata, and Pueraria lobata flower, and extract at 90℃ for 1.5 hours. Filter the mixture. Add 8 times the volume of purified water to the residue and extract for another hour. Combine the two extracts to obtain an aqueous extract. Next, add 8 times the weight volume of the original medicinal materials of sea buckthorn, dried tangerine peel and licorice to 60% ethanol, reflux for 1.5 hours, filter, and recover the ethanol under reduced pressure until there is no alcohol taste to obtain concentrated liquid. Combine the aqueous extract and the concentrate, concentrate under reduced pressure at 60°C to a concentrated paste with a relative density of 1.10, add 20% to 30% of the concentrated paste volume of maltodextrin and stir to dissolve, spray dry, set the inlet air temperature to 165°C and the outlet air temperature to 80°C, and obtain a powdered medicinal and edible extract. S2. Preparation of probiotic post-biotic powder: Take Lactobacillus plantarum, Lactobacillus paracasei and Lactobacillus rhamnosus in a 1:1:1 ratio as the seed liquid for fermentation. Prepare the fermentation culture medium: 1-3% kudzu root water extract, 0.5-2% Japanese raisin tree fruit water extract, 2-5% fructooligosaccharides, 1-2% peptone, 0.5-1% yeast extract, 0.1%-0.3% dipotassium hydrogen phosphate, 0.02%-0.05% magnesium sulfate, and the balance purified water, adjusting the pH to 6.8-7.0; Inoculate the seed culture into the fermentation medium at a rate of 3-4%, and anaerobic ferment at 37°C for 24 hours to produce organic acids, polypeptides, polysaccharides, cell wall components, and related metabolites in the fermentation broth. Monitor the OD600 and pH values of the fermentation broth. Terminate fermentation when the pH drops below 4.0 and the viable cell count reaches 10^9 CFU / mL or higher. Inactivate the cells in an 80°C water bath for at least 20 minutes, ensuring complete inactivation. Centrifuge at 8000 rpm for 15 minutes and collect the mixture of cells and supernatant. Add 8% trehalose and 15% maltodextrin as freeze-drying protectants, stir to dissolve and freeze-dry to obtain probiotic post-biotic powder; the freeze-drying conditions are: pre-freezing at -50℃, vacuum degree below 10Pa, sublimation drying for 24h, and desorption drying for 8h to obtain probiotic post-biotic powder. S3, Preparation of Metabolization-Promoting Layer Particles Take the prescribed amounts of the medicinal and edible homologous extract obtained from S1 and the probiotic post-biotic powder obtained from S2, and mix them in three dimensions with the prescribed amounts of corn oligopeptides, taurine, L-cysteine, L-alanine, L-theanine, vitamin B1, vitamin B2, vitamin B6, and nicotinamide for 20 minutes at a speed of 12 rpm to obtain metabolic-promoting layer particles; control the relative humidity of the environment to be below 40% to ensure that the moisture content of the mixture is below 5%, and after mixing evenly, take samples to test the content uniformity; the RSD should be less than 5%. S4. Preparation of gastric intragastric film-forming carrier: Take the prescribed amounts of low-methoxyl pectin, sodium alginate, resistant dextrin, chitosan, calcium carbonate and sodium citrate, pass them through an 80-mesh sieve, and mix them evenly to obtain the gastric film-forming carrier. Among them, low-methoxyl pectin and sodium alginate form a viscous gel upon contact with gastric juice; calcium carbonate releases calcium ions in an acidic environment, promoting the formation of a gel network; chitosan enhances the adhesion of the gastric mucosa; and resistant dextrin serves as a substrate that can be utilized by intestinal flora and improves taste and formability. S5. Granulation and Drying: The metabolic-enhancing granules obtained from S3 are mixed with the prescribed amount of citric acid, half the prescribed amount of maltodextrin, and erythritol. An appropriate amount of 50% ethanol solution is added to make a soft mass, which is "formed into a ball when squeezed by hand, and easily dispersed when touched". Wet granulation is performed, and the granules are passed through an 18-mesh sieve. The wet granules are spread evenly on a drying tray with a thickness of 2-3 cm and air-dried at 55℃ for 3 hours. The granules are then sized through a 20-mesh sieve, and the prescribed amount of magnesium stearate and natural peppermint flavoring are added. The mixture is mixed for 5 minutes to obtain the metabolic-enhancing granules. The gastric film-forming carrier obtained from S4 is mixed with half the amount of maltodextrin and erythritol in the prescription, and then wet-granulated, dried and sized in the same way. The amount of magnesium stearate in the prescription is added and mixed evenly to obtain the film-forming particles. S6: Double-layer tableting Tableting is performed using a double-layer rotary tablet press: 1. First, add the film-forming particles to the first feeding hopper, fill the middle mold, and pre-press to form; 2. Then add the metabolic-promoting layer particles to the second feeding hopper, filling the film-forming layer; 3. Main compression molding, with tableting pressure controlled at 50-80kN and tablet weight difference controlled within ±5%; 4. The hardness of the resulting bilayer tablets should be controlled at 4-6 kgf, the friability should be less than 1%, and the disintegration time should be: gel formation should begin within 30 seconds after chewing in simulated gastric juice, and a stable gel layer should be formed within 5 minutes.
[0008] S7: Quality Control and Packaging The properties, weight variation, disintegration time, gel strength, content determination, microbial limits, and moisture content of each batch of product were tested, including: Characteristics: Double-layered sheets, uniform color, no cracked or loose sheets; Weight variation: Complies with the requirements for tablets in the Chinese Pharmacopoeia; Disintegration time: Film formation time in simulated gastric juice after chewing ≤ 5 minutes; Gel strength: Measured using a rheometer, the viscosity of the gel formed in simulated gastric juice is ≥1000 mPa·s; Content determination: The contents of index components such as puerarin and dihydromyricetin were determined by HPLC. Microbial limits: Meets the microbial limit standards for food in the Chinese Pharmacopoeia; Moisture: ≤6.0%.
[0009] Once the product passes inspection, it becomes a finished product. It is packaged in aluminum-plastic blister packs or sealed in plastic bottles and stored in a cool, dry place.
[0010] This invention features a scientifically sound formula, abundant raw materials, convenient use, easy-to-operate preparation method, high product quality, and ease of use. Through a three-tiered intervention strategy of "physical barrier in the stomach - intestinal flora regulation - enhanced liver metabolism," it achieves comprehensive therapeutic effects by delaying alcohol absorption, regulating intestinal microecology, promoting alcohol metabolism, and protecting liver cells. It can significantly prolong the latency period of intoxication, shorten the duration of intoxication, reduce blood alcohol concentration, increase liver ADH / ALDH activity, improve alcoholic liver damage, and regulate intestinal flora structure. It has practical application and promotion value in the field of hangover relief and liver protection. Detailed Implementation
[0011] The specific implementation of the present invention will be described in detail below with reference to examples and specific circumstances.
[0012] The present invention is illustrated by the following embodiments: A phased delivery hepatoprotective and alcohol-relieving composition based on hepato-gut axis regulation comprises a food-derived metabolizing component, a hepato-gut axis regulating and acetaldehyde metabolism promoting component, and a gastric film-forming and intestinal sustained-release carrier component. The food-derived metabolizing component is 280g of a food-derived compound extract. The hepato-gut axis regulating and acetaldehyde metabolism promoting component consists of 48g of probiotic postbiotic powder, 40g of corn oligopeptides, 12g of taurine, 6g of L-cysteine, 6g of L-alanine, 0.6g of vitamin B1, 0.4g of vitamin B2, and vitamin B6. This product is made from 0.4g of nicotinamide, 1.2g of L-theanine, 8g of peppermint flavor, and 2g of other ingredients. The gastric film-forming and intestinal sustained-release carrier components are made from 32g of low-methoxyl pectin, 20g of sodium alginate, 60g of resistant dextrin, 8g of chitosan, 8g of calcium carbonate, 6g of sodium citrate, 200g of maltodextrin, 120g of erythritol, 6g of citric acid, 10g of magnesium stearate, and 2g of peppermint flavor; (4g per serving) S1. Preparation of extracts derived from both food and medicine: Take the following ingredients in a weight ratio of 10:8:4:3:2:1: crush the following herbs: Hovenia dulcis, Pueraria lobata, Pueraria lobata flower, Hippophae rhamnoides, Citrus reticulata peel, and Glycyrrhiza uralensis, and pass them through a 20-mesh sieve. Add 10 times the weight volume of purified water to the crushed Hovenia dulcis, Pueraria lobata, and Pueraria lobata flower, and extract at 90℃ for 1.5 hours. Filter the mixture. Add 8 times the volume of purified water to the residue and extract for another hour. Combine the two extracts to obtain an aqueous extract. Next, add 8 times the weight volume of the original medicinal materials of sea buckthorn, dried tangerine peel and licorice to 60% ethanol, reflux for 1.5 hours, filter, and recover the ethanol under reduced pressure until there is no alcohol taste to obtain concentrated liquid. Combine the aqueous extract and the concentrate, concentrate under reduced pressure at 60°C to a concentrated paste with a relative density of 1.10, add 20% to 30% of the concentrated paste volume of maltodextrin and stir to dissolve, spray dry, set the inlet air temperature to 165°C and the outlet air temperature to 80°C, and obtain a powdered medicinal and edible extract. S2. Preparation of probiotic post-biotic powder: Take 50 mL each of the three-stage seed cultures of Lactobacillus plantarum, Lactobacillus paracasei, and Lactobacillus rhamnosus, mix them in a 1:1:1 ratio, inoculate them into 5 L of fermentation medium, and anaerobic ferment at 37 °C for 24 h. Terminate fermentation when the pH drops to 3.8 and the viable cell count reaches 2 × 10^9 CFU / mL. Inactivate the bacteria in an 80 °C water bath for 20 min, ensuring complete inactivation. Centrifuge at 8000 rpm for 15 min and collect the bacterial cells and supernatant mixture. Add 8% trehalose and 15% maltodextrin to the bacterial cells and supernatant mixture, stir to dissolve, and freeze dry to obtain probiotic post-biotic powder; S3, Preparation of Metabolization-Promoting Layer Particles Take the prescribed amounts of the medicinal and edible homologous extract obtained from S1 and the probiotic post-biotic powder obtained from S2, and mix them in three dimensions for 20 minutes at 12 rpm with 40g of corn oligopeptide, 12g of taurine, 6g of L-cysteine, 6g of L-alanine, 8g of L-theanine, 0.6g of vitamin B1, 0.4g of vitamin B2, 0.4g of vitamin B6, and 1.2g of nicotinamide to obtain metabolic-promoting layer particles. Control the relative humidity of the environment to be below 40% and ensure that the moisture content of the mixture is below 5%. After mixing evenly, take a sample to test the content uniformity. The RSD should be less than 5%. S4. Preparation of gastric intragastric film-forming carrier: Take 32g of low-methoxyl pectin, 20g of sodium alginate, 60g of resistant dextrin, 8g of chitosan, 8g of calcium carbonate, and 6g of sodium citrate, sieve them, mix them evenly, and you will get the gastric film-forming carrier. Among them, low-methoxyl pectin and sodium alginate form a viscous gel upon contact with gastric juice; calcium carbonate releases calcium ions in an acidic environment, promoting the formation of a gel network; chitosan enhances the adhesion of the gastric mucosa; and resistant dextrin serves as a substrate that can be utilized by intestinal flora and improves taste and formability. S5. Granulation and Drying: Mix the S3-obtained metabolic-enhancing granules with 6g of citric acid, 100g of maltodextrin, and 60g of erythritol. Add an appropriate amount of 50% ethanol solution to make a soft mass, which should be "clump together when squeezed in the hand, but crumble easily when touched". Perform wet granulation, pass through an 18-mesh sieve, spread the wet granules evenly on a drying tray with a thickness of 2-3cm, and air dry at 55℃ for 3 hours. Perform granulation through a 20-mesh sieve, add the prescribed amount of magnesium stearate and natural peppermint flavoring, mix for 5 minutes, and obtain the metabolic-enhancing granules. The gastric film-forming carrier obtained from S4 was mixed with 100g of maltodextrin and 60g of erythritol, and then wet-granulated, dried and sized using the same method. 6g of magnesium stearate was added and mixed evenly to obtain film-forming particles. S6: Double-layer tableting Tableting is performed using a double-layer rotary tablet press: 1. First, add the film-forming particles to the first feeding hopper, fill the middle mold, and pre-press to form; 2. Then add the metabolic-promoting layer particles to the second feeding hopper, filling the film-forming layer; 3. Main compression molding, with tableting pressure controlled at 50-80kN and tablet weight difference controlled within ±5%; 4. The hardness of the resulting bilayer tablets should be controlled at 4-6 kgf, the friability should be less than 1%, and the disintegration time should be: gel formation should begin within 30 seconds after chewing in simulated gastric juice, and a stable gel layer should be formed within 5 minutes.
[0013] S7: Quality Control and Packaging The properties, weight variation, disintegration time, gel strength, content determination, microbial limits, and moisture content of each batch of product were tested, including: Characteristics: Double-layered sheets, uniform color, no cracked or loose sheets; Weight variation: Complies with the requirements for tablets in the Chinese Pharmacopoeia; Disintegration time: Film formation time in simulated gastric juice after chewing ≤ 5 minutes; Gel strength: Measured using a rheometer, the viscosity of the gel formed in simulated gastric juice is ≥1000 mPa·s; Content determination: The contents of index components such as puerarin and dihydromyricetin were determined by HPLC. Microbial limits: Meets the microbial limit standards for food in the Chinese Pharmacopoeia; Moisture: ≤6.0%.
[0014] Once the product passes inspection, it becomes a finished product. It is packaged in aluminum-plastic blister packs or sealed in plastic bottles and stored in a cool, dry place.
[0015] The compositions given in the above embodiments can be prepared in any quantity as needed. The given embodiments are only for illustrating specific implementations of the present invention and are not intended to limit the scope of protection of the present invention.
[0016] In the drug combinations given above, the mechanisms of action of each component are as follows: (a) Phase A: Metabolizing components derived from both food and medicine Hovenia dulcis extract: The main active ingredients are dihydromyricetin (DHM) and hops flavonoids. Its mechanisms of action include: activating hepatic ADH and ALDH activity, accelerating ethanol and acetaldehyde metabolism; dihydromyricetin can directly bind to acetaldehyde to form a non-toxic complex, reducing acetaldehyde toxicity; inhibiting oxidative stress, increasing the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px); alleviating hepatocyte steatosis, and inhibiting the release of inflammatory factors TNF-α and IL-6.
[0017] Kudzu root extract: The main active ingredients are puerarin, daidzein, and other isoflavones. Its mechanisms of action include: activating hepatic ADH and ALDH activity, promoting alcohol metabolism; inhibiting alcohol absorption in the gastrointestinal tract, reducing peak blood alcohol levels; improving hepatic microcirculation, alleviating alcoholic liver damage; and by regulating gut microbiota, enriching beneficial bacteria that produce short-chain fatty acids (SCFAs), repairing intestinal barrier function, and reducing endotoxin (LPS) leakage.
[0018] Kudzu flower extract: The main active ingredients are total flavonoids from kudzu flower, irisin, saponins, etc. Its mechanisms of action include: inhibiting gastrointestinal alcohol absorption, reducing the amount of ethanol entering the bloodstream by approximately 30%, and enhancing the first-pass effect in the gastrointestinal tract; activating hepatic ADH and ALDH activity, reducing the concentration of ethanol and acetaldehyde in the blood; isoflavone components alleviating alcohol-induced central nervous system depression, improving symptoms such as dizziness and drowsiness; and protecting the gastric mucosa, reducing the direct irritation and damage to the gastric mucosa caused by alcohol.
[0019] Sea buckthorn extract: Its mechanisms of action include: potent antioxidant activity, scavenging reactive oxygen species (ROS) free radicals produced by alcohol metabolism; protecting hepatocyte mitochondrial function and improving energy metabolism; promoting the repair and regeneration of damaged hepatocytes; and regulating immune function and reducing alcohol-induced inflammatory responses.
[0020] Tangerine peel extract: The active ingredients are flavonoids such as hesperidin and tangeretin, as well as volatile oils. Its mechanisms of action include: regulating qi and strengthening the spleen, improving gastrointestinal dysfunction caused by alcohol; promoting bile secretion and aiding lipid metabolism; anti-inflammatory and antioxidant effects, protecting the gastrointestinal mucosa; and enhancing liver detoxification function.
[0021] Licorice extract: The active ingredients are glycyrrhizic acid, glycyrrhizin, and glycyrrhizin flavonoids. Mechanisms of action include: glycyrrhizin flavonoids can increase ALDH activity and accelerate acetaldehyde metabolism; glycyrrhizic acid has a glucocorticoid-like anti-inflammatory effect, reducing liver inflammation; it clears heat and detoxifies, tonifies the spleen and replenishes qi, and protects hepatocytes; it harmonizes other herbs and enhances the synergistic effect of the formula.
[0022] (II) Phase B: Components that regulate the gut-liver axis and promote acetaldehyde metabolism: Probiotic postbiotic powder: Postbiotics refer to non-living microorganisms and / or their metabolites that are beneficial to the health of the host. This invention uses a combination of multiple strains of Lactobacillus plantarum, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus rhamnosus, and Bacillus coagulans to prepare postbiotic powder through compound fermentation. The mechanisms of action include: a) Intestinal barrier repair: Upregulating the expression of tight junction proteins ZO-1, Occludin, and Claudin-1, repairing the integrity of the intestinal mucosa, and reducing endotoxin translocation; b) Microbiome regulation: Promoting the proliferation of beneficial bacteria such as Bifidobacteria, Lactobacillus, and Akkermansia, and inhibiting the growth of opportunistic pathogens; c) Immune regulation: By activating the intestinal dendritic cell-3 innate lymphocyte (DCs-ILC3) axis and its mediated NOD2-IL-22 signaling pathway, promoting the activation of liver STAT3 signaling, and accelerating liver damage repair; d) Metabolite supply: Rich in short-chain fatty acids (butyric acid, propionic acid, etc.), γ-aminobutyric acid, extracellular polysaccharides, bacteriocins, and other active substances, providing energy for the intestinal epithelium, inhibiting inflammation, and providing antioxidant effects; e) Stability advantage: Compared with live probiotics, postbiotics are resistant to gastric acid, have stable storage, precise dosage, no risk of infection, and higher safety.
[0023] Corn oligopeptides are small molecule bioactive peptides obtained from corn gluten meal through targeted enzymatic hydrolysis. Their average molecular weight is less than 1000 Da. Their mechanisms of action include: significantly enhancing liver ADH and ALDH activity, accelerating alcohol metabolism; increasing glutathione (GSH) levels in the liver and blood, enhancing antioxidant capacity; increasing plasma levels of alanine, leucine, and proline, providing NAD+ precursors for ADH and ALDH; being rich in branched-chain amino acids, alleviating alcohol-induced central fatigue; and protecting hepatocytes, reducing alcoholic liver damage.
[0024] Taurine: A sulfur-containing non-protein amino acid widely distributed in human tissues. Its mechanisms of action include: binding with acetaldehyde to form stable adducts, reducing acetaldehyde toxicity; acting as an antioxidant, stabilizing cell membranes, and protecting liver cells; relieving fatigue, protecting cardiomyocytes, and reducing the burden of alcohol on the heart; regulating neurotransmitters, improving hangover-induced headaches and anxiety; and promoting bile secretion, aiding lipid metabolism.
[0025] L-cysteine is a sulfur-containing amino acid and a precursor for glutathione synthesis. Its mechanisms of action include: direct thiol addition with acetaldehyde to form non-toxic 2-methylthiazolidin-4-carboxylic acid, accelerating acetaldehyde clearance; supplementing glutathione precursors and enhancing the antioxidant capacity of hepatocytes; repairing damaged hepatocytes and promoting tissue regeneration; and enhancing liver detoxification function.
[0026] L-Alanine: A non-essential amino acid involved in gluconeogenesis and energy metabolism. Its mechanisms of action include: acting as a precursor to NAD+ synthesis, enhancing the supply of coenzymes for ADH and ALDH; promoting energy regeneration during alcohol metabolism; stabilizing blood sugar and alleviating dizziness and weakness caused by post-drinking hypoglycemia; protecting liver function and promoting ammonia metabolism.
[0027] B vitamins (B1, B2, B6, niacinamide): Alcohol metabolism consumes a large amount of B vitamins, making supplementation important: Vitamin B1 (thiamine): Acts as a coenzyme in glucose metabolism, preventing alcoholic Wernicke's encephalopathy; Vitamin B2 (riboflavin): Participates in redox reactions, providing a cofactor for ADH / ALDH; Vitamin B6 (pyridoxine): Participates in amino acid metabolism and neurotransmitter synthesis, alleviating hangover symptoms; Niacinamide (vitamin B3): As a precursor to NAD+ / NADPH, it is a key coenzyme in alcohol metabolism.
[0028] L-Theanine: A non-protein amino acid unique to tea. Its mechanisms of action include: promoting the generation of alpha waves in the brain, relieving anxiety and irritability after drinking; regulating the levels of neurotransmitters dopamine and serotonin, improving hangover headaches; antioxidant and neuroprotective effects; and synergistically enhancing the calming and soothing effects of other components.
[0029] (III) Phase C: Gastric film-forming and intestinal sustained-release carrier components: Low-methoxylated pectin (LM pectin) is pectin with an esterification degree of less than 50%, which can form a gel in the presence of calcium ions. Its mechanism of action includes: combining with gastric acid and calcium ions to form a viscous gel network, physically encapsulating ethanol molecules; forming an adhesive protective layer on the gastric mucosa surface, blocking the direct irritation of the gastric mucosa by alcohol; delaying gastric emptying, slowing the rate of ethanol absorption into the bloodstream, and reducing peak blood alcohol levels; and acting as a prebiotic, promoting the proliferation of beneficial intestinal bacteria.
[0030] Sodium alginate: A natural polysaccharide extracted from brown algae, possessing excellent biocompatibility and gelling properties. Its mechanism of action includes: forming an alginate gel in an acidic environment, enhancing gastric film formation; synergistically constructing a dense gel network with pectin, increasing ethanol adsorption capacity; the resulting gel exhibits buoyancy and can remain in the stomach for 4-6 hours; and acting as a sustained-release carrier, controlling the release rate of active ingredients in the intestine.
[0031] Resistant dextrin: a low-molecular-weight, water-soluble dietary fiber. Its mechanisms of action include: acting as a prebiotic, it is fermented by gut microbiota to produce short-chain fatty acids; improving the rheological properties of the gel matrix, optimizing taste and formability; delaying gastric emptying and smoothing postprandial blood glucose fluctuations; and promoting intestinal motility and accelerating toxin elimination.
[0032] Chitosan: A deacetylated product of chitin, possessing excellent bioadhesion and biocompatibility. Its mechanisms of action include: the interaction of positively charged amino groups with negatively charged gastric mucosal mucin, enhancing gel adhesion to the gastric wall; antibacterial and anti-inflammatory effects, protecting the gastric mucosa; microcapsules formed by polyelectrolyte complexation with sodium alginate, achieving sustained intestinal release; and regulation of blood lipids, reducing the metabolic burden on the liver.
[0033] Calcium carbonate: as a calcium source and pH regulator. Its mechanisms of action include: releasing calcium ions in the acidic environment of the stomach, triggering the gelation reaction of low-methoxyl pectin; neutralizing some stomach acid, reducing the irritation of alcohol on the gastric mucosa; regulating the rate and strength of gel formation; and acting as an antacid to relieve heartburn after drinking alcohol.
[0034] Sodium citrate: Acts as a buffer and chelating agent. Its mechanisms of action include: regulating the pH of the system and controlling gel formation kinetics; forming a chelation-release balance with calcium ions to achieve gradual gelation; improving taste and masking bitterness; and acting as an electrolyte supplement to alleviate post-drinking dehydration.
[0035] This invention achieves a systemic effect of detoxifying the liver and protecting it through an innovative design of "three-level intervention, phased delivery, and multi-target synergy": Level 1: Intragastric physical barrier and rapid onset of action: After chewing, the pectin and sodium alginate in phase C rapidly form an adhesive gel network under the action of gastric acid and calcium ions. On the one hand, this forms a physical protective layer on the gastric mucosa, blocking the direct irritation of alcohol to the stomach wall; on the other hand, it adsorbs and encapsulates some ethanol molecules, slowing gastric emptying and ethanol absorption, reducing peak blood alcohol concentration, and buying time for liver metabolism. At the same time, some of the pueraria flavonoids and glycyrrhizic acid in phase A are rapidly released, exerting a local protective effect in the stomach.
[0036] Level Two: Gut-Hepatobiliary Axis Regulation and Microbiome Repair Once inside the intestines, the probiotic postbiotic powder (phase B) and the plant extracts (phase A) work synergistically: the postbiotics repair the intestinal tight junction barrier, reducing endotoxin translocation; they regulate the intestinal flora structure, increasing the abundance of beneficial bacteria that produce SCFAs; and the plant extracts improve the liver metabolic environment through the flora-bile acid-liver axis. Together, they block the pathological chain of "enterogenic endotoxemia-liver inflammation" from upstream.
[0037] Level 3: Enhanced liver metabolism and cell protection: The A-phase compound extract of medicinal and edible ingredients (containing active components of Japanese raisin tree fruit, kudzu root, kudzu flower, sea buckthorn, tangerine peel, and licorice) works synergistically with the B-phase ingredients of corn oligopeptides, L-cysteine, taurine, and B vitamins to enhance alcohol metabolism from multiple levels: Enzyme activity level: Puerarin and corn oligopeptides synergistically activate ADH / ALDH activity; Substrate supply: L-alanine and nicotinamide provide NAD+ coenzyme precursors; Toxin removal: L-cysteine and taurine directly bind to acetaldehyde; Antioxidant benefits: Sea buckthorn flavonoids, dihydromyricetin, and glutathione work together to scavenge ROS; At the cellular protection level: glycyrrhizic acid and post-genetic metabolites work synergistically to reduce inflammation and promote liver cell repair.
[0038] Timing coordination of phased delivery: The gastric film-forming layer takes effect immediately (5-10 minutes), exerting a physical barrier effect; the metabolic-promoting layer rapidly releases some components (within 30 minutes) to address the rise in blood alcohol levels; the remaining components are released slowly into the intestines (2-6 hours), covering the entire process of alcohol metabolism. This achieves a synergistic effect across the time dimension of "immediate protection - mid-term acceleration - long-term repair," resulting in good efficacy, high efficiency, and a short cycle. Experiments have demonstrated very good and beneficial technical results, and the relevant experimental materials are as follows: I. Gel formation verification experiment: Take one double-layer chewable tablet prepared according to the method in the example, chew it finely, add 100 mL of simulated gastric juice (0.1 mol / L HCl, pH 1.2, 37℃), stir magnetically for 50 rpm, and observe the gel formation.
[0039] Results: The viscosity of the system began to increase within 30 seconds, a visible gel-like structure formed within 2 minutes, and a stable semi-floating gel layer formed within 5 minutes. The gel viscosity was measured to be 2850 mPa·s using a rheometer. 50 mL of 52-degree baijiu (Chinese liquor) was added to the above gel system, stirred, and allowed to stand. Ethanol was observed to be adsorbed and encapsulated by the gel network, and the alcohol content of the supernatant decreased significantly (from 52% to 38%), demonstrating that the gel has a significant ethanol adsorption and retention capacity.
[0040] II. Experiment on the detoxification effect on acute alcohol poisoning in mice: 1. Experimental materials: Experimental animals: 60 male SPF-grade Kunming mice, weighing 18–22g; Test sample: The hangover relief and liver protection composition prepared by the method of the example (ground into powder and suspended in 0.5% CMC-Na); Comparison sample: A commercially available brand of hangover relief tablets (main ingredients are kudzu root and turmeric); Reagents: 56-degree liquor, ADH and ALDH detection kit; 2. Experimental Methods: Mice were randomly divided into 5 groups of 12 mice each: Blank control group: equal volume of physiological saline; Model control group: an equal volume of physiological saline; Positive control group: Lieber-DeCarli alcoholic liquid feed, dose 1.0 g / kg; The low-dose group of this invention: 0.5 g / kg; The high-dose group of this invention: 1.0 g / kg; Thirty minutes after administration of the drug via gavage, all groups except the control group were administered 0.15 mL / 10 g body weight of 56% ABV liquor via gavage. Observation records: Intoxication latency period (time when righting reflex disappears); Duration of intoxication (righting reflex recovery time); Blood samples were taken from the orbital cavity 2 and 4 hours after drinking to determine the blood ethanol concentration. Mice were euthanized after the experiment, and their livers were harvested to measure ADH and ALDH activity.
[0041] 3. Experimental Results: Table 1. Comparison of alcohol intoxication levels in mice across different groups (x̄±s, n=12)
[0042] Note: Compared with the model group, *P<0.05, **P<0.01 Table 2 Comparison of serum alcohol concentrations in mice of different groups (x̄±s, n=12, mmol / L)
[0043] Table 3 Comparison of ADH and ALDH activities in the liver of mice in each group (x̄±s, n=12)
[0044] 4. Conclusion: The composition of this invention can significantly prolong the latency period of intoxication in mice, shorten the duration of intoxication, reduce blood ethanol concentration, and significantly increase liver ADH and ALDH activity. The effect is superior to similar commercially available products and is dose-dependent.
[0045] III. Protective effect against alcoholic liver injury in mice: 1. Experimental Methods: A mouse model of chronic alcoholic liver injury was established using Lieber-DeCarli alcoholic liquid diet. Forty mice were randomly divided into four groups: normal group, model group, low-dose group (0.5 g / kg) and high-dose group (1.0 g / kg) of the present invention, and administered the drug by gavage for 8 consecutive weeks.
[0046] After the last administration, blood was drawn from the orbital cavity to detect serum ALT, AST, TG, and TC levels; liver tissue was taken to measure SOD, GSH-Px activities, and MDA content; HE staining was used to observe pathological changes in liver tissue; and 16S rDNA sequencing was used to analyze changes in intestinal flora.
[0047] 2. Experimental Results Table 4 Comparison of liver function indicators among different groups of mice (x̄±s, n=10)
[0048] Table 5 Comparison of liver oxidative stress indices in mice of different groups (x̄±s, n=10)
[0049] Gut microbiota analysis results: The model group mice showed a significant decrease in gut microbiota diversity, an imbalance in the ratio of Bacteroidetes to Firmicutes, a decrease in the abundance of Bifidobacteria and Lactobacillus, and an increase in opportunistic pathogens such as Escherichia coli. The drug administration group of this invention can significantly improve the α-diversity of the bacterial community, increase the abundance of Lactobacillus, Bifidobacterium, and Akkermansia, and decrease the proportion of Bacteroides and Desulfovibrio. Metabolomics showed that the content of short-chain fatty acids such as butyric acid and propionic acid in the feces of the drug administration group was significantly increased, which was positively correlated with the abundance of beneficial bacteria.
[0050] 3. Conclusion The composition of this invention has a significant protective effect against chronic alcoholic liver injury, can improve liver function, reduce hepatic steatosis, enhance antioxidant capacity, and effectively regulate the intestinal flora structure, thus verifying the mechanism of action of the hepato-gut axis regulation.
[0051] IV. Preliminary observations from human trials: 1. Subject selection: Thirty healthy adult volunteers, aged 22-45, with a history of alcohol consumption for more than one year and no history of liver disease, were selected and signed an informed consent form.
[0052] 2. Test methods: A self-controlled design was used. Participants took two tablets of the product of this invention 30 minutes before drinking alcohol and consumed 100 mL (approximately 2 liang) of 52-proof liquor. Blood ethanol concentrations were measured before drinking, and at 1 hour, 2 hours, and 4 hours after drinking. Hangover symptom scores (0–10 points) such as headache, dizziness, nausea, and dry mouth were recorded. A blank control trial was conducted one week later (participants did not take the medication and consumed the same amount of alcohol).
[0053] 3. Experimental Results: Table 6. Changes in blood alcohol concentration in subjects (x̄±s, n=30, mg / 100mL)
[0054] Table 7 Comparison of hangover symptom scores among subjects (x̄±s, n=30, points)
[0055] 4. Conclusion: Human trials have shown that the product of this invention can significantly reduce blood ethanol concentration after drinking alcohol, effectively relieve hangover symptoms such as headache, dizziness, nausea, and stomach discomfort. Subjects tolerated it well and no obvious adverse reactions were found.
[0056] In summary, this invention provides a phased delivery composition for hangover relief and liver protection based on the gut-liver axis regulation. It is the first to systematically apply the gut-liver axis theory to the field of hangover relief, pioneering a phased delivery technology of "gastric film formation - intestinal sustained release." It integrates five major categories of active ingredients: extracts from medicinal and edible plants, probiotic postbiotics, active peptides, functional amino acids, and B vitamins, achieving a full-chain intervention of "delayed absorption - regulation of gut microbiota - promotion of metabolism - protection of the liver." Pharmacological experiments have confirmed that this composition can significantly prolong the latency period of intoxication, shorten the duration of intoxication, reduce blood alcohol concentration, increase hepatic ADH / ALDH activity, improve alcoholic liver damage, and regulate gut microbiota structure. Human trials have verified its good hangover relief effect and hangover-relieving effect.
[0057] The technical solution of this invention is scientifically sound and reasonable, the preparation process is stable and controllable, and the product is safe, effective, and easy to use. It has significant innovative and practical value in the field of alcohol detoxification and liver protection, with broad market application prospects. It can provide a new technical means for the prevention and intervention of alcoholic liver injury. Compared with existing technologies, the innovation and advantages of this invention are: (I) Theoretical Innovation: For the first time, a new strategy for hangover relief based on "liver-gut axis regulation" was systematically proposed. Breaking away from the traditional single-target approach of "only targeting the liver," this approach constructs a three-tiered intervention system based on the gut-liver axis theory, encompassing "gastric barrier - intestinal regulation - liver metabolism." It not only enhances the liver's ability to metabolize alcohol but also repairs the intestinal barrier upstream, regulates gut microbiota structure, reduces endotoxin translocation, and blocks the pathological chain of "gut-related inflammation - liver damage," achieving both symptomatic and root-cause treatment.
[0058] (II) Technological Innovation: Pioneering "phase-by-phase delivery" hangover remedy technology: The tablet uses a dual-layer chewable design to achieve spatiotemporal delivery of the gastric film-forming layer and the metabolic-promoting layer: In the gastric phase: The pectin-sodium alginate-calcium system rapidly forms an adhesive gel in the acidic environment of the stomach, which physically adsorbs ethanol, protects the gastric mucosa, and delays absorption. Intestinal phase: Active ingredients are released slowly into the intestines, continuously exerting their effects on gut microbiota regulation and metabolic enhancement.
[0059] This design perfectly matches the body's absorption and metabolism rhythm of alcohol, significantly improving bioavailability and intervention effectiveness.
[0060] (III) Ingredient Innovation: The Pioneering Application of Probiotic Postbiotics in the Field of Hangover Relief: This is the first time that a multi-strain compound postbiotic system has been applied to a hangover relief and liver protection product, avoiding technical challenges such as poor acid resistance, low colonization rate, and unstable storage of live probiotics. The postbiotic is rich in short-chain fatty acids, extracellular polysaccharides, γ-aminobutyric acid, and other active metabolites, possessing multiple functions including barrier repair, immune regulation, anti-inflammatory, and antioxidant effects. It is highly safe, with precise dosage and controllable quality.
[0061] (iv) Formulation innovation: Scientific combination of multiple components and multiple targets: This product integrates five major categories of active ingredients: extracts from medicinal and edible plants, probiotic postbiotics, active peptides, functional amino acids, and B vitamins, achieving synergistic effects from the following seven dimensions: 1. Physically blocks absorption; 2. Enhances ADH / ALDH enzyme activity; 3. Directly binds to and eliminates acetaldehyde; 4. Repairs intestinal barrier function; 5. Regulates intestinal microecological balance; 6. Antioxidant effect reduces liver damage; 7. Nutritional supplementation relieves hangovers; The components work synergistically to achieve a systemic effect of "1+1>2".
[0062] (V) Safety Advantages: All ingredients are of medicinal and edible grade, with extremely high safety. All raw materials are selected from the list of food and medicine homology or the list of new resource foods published by the National Health Commission. They contain no drug ingredients, have no toxic side effects, and can be taken for a long time. Post-biotics are inactivated bacteria, so there is no risk of live bacteria infection, and they are suitable for a wider range of people (including people with low immunity).
[0063] (vi) Dosage form advantages: Double-layer chewable tablets, good compliance: Chewable tablets require no water to take, making them convenient to carry and consume anytime, anywhere, especially suitable for social occasions and parties. Their dual-layer structure combines functionality and fun, offering a pleasant taste that is easily accepted by consumers.
Claims
1. A phased delivery hepatoprotective and alcohol-relieving composition based on gut-liver axis regulation, comprising a food-derived metabolic-promoting component, a gut-liver axis regulating and acetaldehyde metabolism-promoting component, and a gastric film-forming and intestinal sustained-release carrier component. The food-derived metabolic-promoting component is prepared from 30-75 parts of a food-derived compound extract. The gut-liver axis regulating and acetaldehyde metabolism-promoting component comprises 5-25 parts of probiotic post-biotic powder, 5-20 parts of corn oligopeptides, 1-8 parts of taurine, 0.5-5 parts of L-cysteine, 0.5-5 parts of L-alanine, 0.05-0.5 parts of vitamin B1, 0.05-0.5 parts of vitamin B2, and 0.05-0.5 parts of vitamin B6. The gastric film-forming and intestinal sustained-release carrier components are composed of 0.05-0.5 parts of nicotinamide, 0.05-1 parts of L-theanine, and 0.5-5 parts of sodium alginate, 3-15 parts of low-methoxyl pectin, 2-12 parts of sodium alginate, 5-25 parts of resistant dextrin, 0.5-5 parts of chitosan, 0.5-5 parts of calcium carbonate, 0.5-5 parts of sodium citrate, 5-50 parts of maltodextrin, 5-30 parts of erythritol, 1-2 parts of citric acid, 1-2 parts of magnesium stearate, and 0.2-1.5 parts of peppermint flavor. S1. Preparation of extracts derived from both food and medicine: Take the following ingredients in a weight ratio of 10:8:4:3:2:1: crush the following herbs: Hovenia dulcis, Pueraria lobata, Pueraria lobata flower, Hippophae rhamnoides, Citrus reticulata peel, and Glycyrrhiza uralensis, and pass them through a 20-mesh sieve. Add 10 times the weight volume of purified water to the crushed Hovenia dulcis, Pueraria lobata, and Pueraria lobata flower, and extract at 90℃ for 1.5 hours. Filter the mixture. Add 8 times the volume of purified water to the residue and extract for another hour. Combine the two extracts to obtain an aqueous extract. Next, add 8 times the weight volume of the original medicinal materials of sea buckthorn, dried tangerine peel and licorice to 60% ethanol, reflux for 1.5 hours, filter, and recover the ethanol under reduced pressure until there is no alcohol taste to obtain concentrated liquid. Combine the aqueous extract and the concentrate, concentrate under reduced pressure at 60°C to a concentrated paste with a relative density of 1.10, add 20% to 30% of the concentrated paste volume of maltodextrin and stir to dissolve, spray dry, set the inlet air temperature to 165°C and the outlet air temperature to 80°C, and obtain a powdered medicinal and edible extract. S2. Preparation of probiotic post-biotic powder: Take Lactobacillus plantarum, Lactobacillus paracasei, and Lactobacillus rhamnosus in a 1:1:1 ratio as the seed culture for fermentation. Prepare the fermentation culture medium: 1-3% kudzu root water extract, 0.5-2% Japanese raisin tree fruit water extract, 2-5% fructooligosaccharides, 1-2% peptone, 0.5-1% yeast extract, 0.1%-0.3% dipotassium hydrogen phosphate, 0.02%-0.05% magnesium sulfate, and the balance purified water, adjusting the pH to 6.8-7.0; Inoculate the seed culture into the fermentation medium at a rate of 3-4%, and anaerobic ferment at 37°C for 24 hours to produce organic acids, polypeptides, polysaccharides, cell wall components, and related metabolites in the fermentation broth. Monitor the OD600 and pH values of the fermentation broth. Terminate fermentation when the pH drops below 4.0 and the viable cell count reaches 10^9 CFU / mL or higher. Inactivate the cells in an 80°C water bath for at least 20 minutes, ensuring complete inactivation. Centrifuge at 8000 rpm for 15 minutes and collect the mixture of cells and supernatant. Add 8% trehalose and 15% maltodextrin as freeze-drying protectants, stir to dissolve and freeze-dry to obtain probiotic post-biotic powder; the freeze-drying conditions are: pre-freezing at -50℃, vacuum degree below 10Pa, sublimation drying for 24h, and desorption drying for 8h to obtain probiotic post-biotic powder. S3, Preparation of Metabolization-Promoting Layer Particles Take the prescribed amounts of the medicinal and edible homologous extract obtained from S1 and the probiotic post-biotic powder obtained from S2, and mix them in three dimensions with the prescribed amounts of corn oligopeptides, taurine, L-cysteine, L-alanine, L-theanine, vitamin B1, vitamin B2, vitamin B6, and nicotinamide for 20 minutes at a speed of 12 rpm to obtain metabolic-promoting layer particles; control the relative humidity of the environment to be below 40% to ensure that the moisture content of the mixture is below 5%, and after mixing evenly, take samples to test the content uniformity; the RSD should be less than 5%. S4. Preparation of gastric intragastric film-forming carrier: Take the prescribed amounts of low-methoxyl pectin, sodium alginate, resistant dextrin, chitosan, calcium carbonate and sodium citrate, pass them through an 80-mesh sieve, and mix them evenly to obtain the gastric film-forming carrier. in, Low-methoxyl pectin and sodium alginate form a viscous gel upon contact with gastric juice; calcium carbonate releases calcium ions in an acidic environment, promoting gel network formation; chitosan enhances gastric mucosal adhesion; resistant dextrin serves as a substrate that can be utilized by intestinal flora and improves taste and formability. S5. Granulation and Drying: The metabolic-enhancing granules obtained from S3 are mixed with the prescribed amount of citric acid, half the prescribed amount of maltodextrin, and erythritol. An appropriate amount of 50% ethanol solution is added to make a soft mass, which is "formed into a ball when squeezed by hand, and easily dispersed when touched". Wet granulation is performed, and the granules are passed through an 18-mesh sieve. The wet granules are spread evenly on a drying tray with a thickness of 2-3 cm and air-dried at 55℃ for 3 hours. The granules are then sized through a 20-mesh sieve, and the prescribed amount of magnesium stearate and natural peppermint flavoring are added. The mixture is mixed for 5 minutes to obtain the metabolic-enhancing granules. The gastric film-forming carrier obtained from S4 is mixed with half the amount of maltodextrin and erythritol in the prescription, and then wet-granulated, dried and sized in the same way. The amount of magnesium stearate in the prescription is added and mixed evenly to obtain the film-forming particles. S6: Double-layer tableting: Tableting is performed using a double-layer rotary tablet press: S6.1 First, add the film-forming particles to the first feeding hopper, fill it into the middle mold, and pre-press it into shape; S6.
2. Next, add the metabolic-promoting layer particles to the second feeding hopper and fill them on top of the film-forming layer; S6.3 Main compression molding, tableting pressure controlled at 50-80kN, tablet weight difference controlled within ±5%; S6.4 The hardness of the obtained bilayer tablets should be controlled at 4-6 kgf, the friability should be less than 1%, and the disintegration time should be: gel should begin to form in simulated gastric juice within 30 seconds after chewing, and a stable gel layer should be formed within 5 minutes. S7: Quality Control and Packaging The properties, weight variation, disintegration time, gel strength, content determination, microbial limits, and moisture content of each batch of product were tested, including: Characteristics: Double-layered sheets, uniform color, no cracked or loose sheets; Weight variation: Complies with the requirements for tablets in the Chinese Pharmacopoeia; Disintegration time: Film formation time in simulated gastric juice after chewing ≤ 5 minutes; Gel strength: Measured using a rheometer, the viscosity of the gel formed in simulated gastric juice is ≥1000 mPa·s; Content determination: The contents of index components such as puerarin and dihydromyricetin were determined by HPLC. Microbial limits: Meets the microbial limit standards for food in the Chinese Pharmacopoeia; Moisture: ≤6.0%; Once the product passes inspection, it becomes a finished product. It is packaged in aluminum-plastic blister packs or sealed in plastic bottles and stored in a cool, dry place.
2. The phased delivery hepatoprotective and alcohol-relieving composition based on hepatic-gut axis regulation according to claim 1, comprising a food-derived metabolizing component, a hepatic-gut axis regulating and acetaldehyde metabolism promoting component, and a gastric film-forming and intestinal sustained-release carrier component, wherein the food-derived metabolizing component is made from 280g of a food-derived compound extract, and the hepatic-gut axis regulating and acetaldehyde metabolism promoting component comprises 48g of probiotic postbiotic powder, 40g of corn oligopeptide, 12g of taurine, 6g of L-cysteine, 6g of L-alanine, 0.6g of vitamin B1, 0.4g of vitamin B2, and vitamin B6. It is made of 0.4g of nicotinamide, 1.2g of L-theanine, 8g of peppermint flavor, and 2g of nicotinamide. The gastric film-forming and intestinal sustained-release carrier components are made of 32g of low-methoxyl pectin, 20g of sodium alginate, 60g of resistant dextrin, 8g of chitosan, 8g of calcium carbonate, 6g of sodium citrate, 200g of maltodextrin, 120g of erythritol, 6g of citric acid, 10g of magnesium stearate, and 2g of peppermint flavor. S1. Preparation of extracts derived from both food and medicine: Take the following ingredients in a weight ratio of 10:8:4:3:2:1: crush the following herbs: Hovenia dulcis, Pueraria lobata, Pueraria lobata flower, Hippophae rhamnoides, Citrus reticulata peel, and Glycyrrhiza uralensis, and pass them through a 20-mesh sieve. Add 10 times the weight volume of purified water to the crushed Hovenia dulcis, Pueraria lobata, and Pueraria lobata flower, and extract at 90℃ for 1.5 hours. Filter the mixture. Add 8 times the volume of purified water to the residue and extract for another hour. Combine the two extracts to obtain an aqueous extract. Next, add 8 times the weight volume of the original medicinal materials of sea buckthorn, dried tangerine peel and licorice to 60% ethanol, reflux for 1.5 hours, filter, and recover the ethanol under reduced pressure until there is no alcohol taste to obtain concentrated liquid. Combine the aqueous extract and the concentrate, concentrate under reduced pressure at 60°C to a concentrated paste with a relative density of 1.10, add 20% to 30% of the concentrated paste volume of maltodextrin and stir to dissolve, spray dry, set the inlet air temperature to 165°C and the outlet air temperature to 80°C, and obtain a powdered medicinal and edible extract. S2. Preparation of probiotic post-biotic powder: Take 50 mL each of the three-stage seed cultures of Lactobacillus plantarum, Lactobacillus paracasei, and Lactobacillus rhamnosus, mix them in a 1:1:1 ratio, inoculate them into 5 L of fermentation medium, and anaerobic ferment at 37 °C for 24 h. Terminate fermentation when the pH drops to 3.8 and the viable cell count reaches 2 × 10^9 CFU / mL. Inactivate the bacteria in an 80 °C water bath for 20 min, ensuring complete inactivation. Centrifuge at 8000 rpm for 15 min and collect the bacterial cells and supernatant mixture. Add 8% trehalose and 15% maltodextrin to the bacterial cells and supernatant mixture, stir to dissolve, and freeze dry to obtain probiotic post-biotic powder; S3. Preparation of metabolic-promoting layer particles: Take the prescribed amounts of the medicinal and edible extract obtained from S1 and the probiotic post-biotic powder obtained from S2, and mix them in three dimensions for 20 minutes at 12 rpm with 40g of corn oligopeptide, 12g of taurine, 6g of L-cysteine, 6g of L-alanine, 8g of L-theanine, 0.6g of vitamin B1, 0.4g of vitamin B2, 0.4g of vitamin B6, and 1.2g of nicotinamide to obtain metabolic-promoting layer particles. Control the relative humidity of the environment to be below 40% and ensure that the moisture content of the mixture is below 5%. After mixing evenly, take a sample to test the content uniformity. The RSD should be less than 5%. S4. Preparation of gastric intragastric film-forming carrier: Take 32g of low-methoxyl pectin, 20g of sodium alginate, 60g of resistant dextrin, 8g of chitosan, 8g of calcium carbonate, and 6g of sodium citrate, sieve them, mix them evenly, and you will get the gastric film-forming carrier. in, Low-methoxyl pectin and sodium alginate form a viscous gel upon contact with gastric juice; calcium carbonate releases calcium ions in an acidic environment, promoting gel network formation; chitosan enhances gastric mucosal adhesion; resistant dextrin serves as a substrate that can be utilized by intestinal flora and improves taste and formability. S5. Granulation and Drying: Mix the S3-obtained metabolic-enhancing granules with 6g of citric acid, 100g of maltodextrin, and 60g of erythritol. Add an appropriate amount of 50% ethanol solution to make a soft mass, which should be "clump together when squeezed in the hand, but crumble easily when touched". Perform wet granulation, pass through an 18-mesh sieve, spread the wet granules evenly on a drying tray with a thickness of 2-3cm, and air dry at 55℃ for 3 hours. Perform granulation through a 20-mesh sieve, add the prescribed amount of magnesium stearate and natural peppermint flavoring, mix for 5 minutes, and obtain the metabolic-enhancing granules. The gastric film-forming carrier obtained from S4 was mixed with 100g of maltodextrin and 60g of erythritol, and then wet-granulated, dried and sized using the same method. 6g of magnesium stearate was added and mixed evenly to obtain film-forming particles. S6: Double-layer tableting: Tableting is performed using a double-layer rotary tablet press: S6.1 First, add the film-forming particles to the first feeding hopper, fill it into the middle mold, and pre-press it into shape; S6.
2. Next, add the metabolic-promoting layer particles to the second feeding hopper and fill them on top of the film-forming layer; S6.3 Main compression molding, tableting pressure controlled at 50-80kN, tablet weight difference controlled within ±5%; S6.4 The hardness of the obtained bilayer tablets should be controlled at 4-6 kgf, the friability should be less than 1%, and the disintegration time should be: gel should begin to form in simulated gastric juice within 30 seconds after chewing, and a stable gel layer should be formed within 5 minutes. S7: Quality Control and Packaging The properties, weight variation, disintegration time, gel strength, content determination, microbial limits, and moisture content of each batch of product were tested, including: Characteristics: Double-layered sheets, uniform color, no cracked or loose sheets; Weight variation: Complies with the requirements for tablets in the Chinese Pharmacopoeia; Disintegration time: Film formation time in simulated gastric juice after chewing ≤ 5 minutes; Gel strength: Measured using a rheometer, the viscosity of the gel formed in simulated gastric juice is ≥1000 mPa·s; Content determination: The contents of index components such as puerarin and dihydromyricetin were determined by HPLC. Microbial limits: Meets the microbial limit standards for food in the Chinese Pharmacopoeia; Moisture: ≤6.0%; Once the product passes inspection, it becomes a finished product. It is packaged in aluminum-plastic blister packs or sealed in plastic bottles and stored in a cool, dry place.
